Moreover, due to relatively high prevalence of carriers in the general population, CAH patients who inherit two severe mutations in the CYP21A2 gene, should encourage their partners for, genetic screening, which is of paramount importance (138). This evidence concerns the gene CYP21A2 and congenital adrenal hyperplasia.